Hepatorenal syndrome: Updates
- PMID: 37663551
- PMCID: PMC10473355
- DOI: 10.1097/CLD.0000000000000024
Hepatorenal syndrome: Updates
Conflict of interest statement
Florence Wong consults for and received grants from Ocelot Bio and Sequana Medical Inc. She received grants from Grifols. She consults for River2Renal Corp. Neha Tiwari has no conflicts to report.
Figures



References
-
- Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. . Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64:531–7. - PubMed
-
- Amathieu R, Al-Khafaji A, Sileanu FE, Foldes E, DeSensi R, Hilmi I, et al. . Significance of oliguria in critically ill patients with chronic liver disease. Hepatology. 2017;66:1592–600. - PubMed
-
- Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR. News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document. J Hepatol. 2019;71:811–22. - PubMed
-
- Allegretti AS, Sola E, Gines P. Clinical Application of kidney biomarkers in cirrhosis. Am J Kidney Dis. 2020;76:710–9. - PubMed
LinkOut - more resources
Full Text Sources